Prescription Fill Rates for Alzheimer Disease and Related Dementias: What's the Pattern? - Neurology Advisor

7/7/2022 12:00:00 AM2 years 9 months ago
Researchers sought to examine prescription drug fills for cognitive and behavioral symptoms of ADRD among patients enrolled in Medicare Advantage Part D.
Acetylcholinesterase or N-methyl-D-aspartate (NMDA) receptor antagonists may be utilized as preemptive medication before a formal diagnosis of Alzheimer disease and related dementias (ADRDs), accordi… [+3380 chars]
full article...